[HTML][HTML] Clinical and therapeutic implications of Epstein–Barr virus in HIV-related lymphomas

M Verdu-Bou, G Tapia, A Hernandez-Rodriguez… - Cancers, 2021 - mdpi.com
Simple Summary Epstein–Barr virus (EBV) is involved in lymphomagenesis, especially
lymphomas affecting populations with immunodeficiencies, such as people living with HIV …

[HTML][HTML] Potential pathogenic impact of cow's milk consumption and bovine milk-derived exosomal MicroRNAs in diffuse large B-Cell lymphoma

BC Melnik, R Stadler, R Weiskirchen… - International Journal of …, 2023 - mdpi.com
Epidemiological evidence supports an association between cow's milk consumption and the
risk of diffuse large B-cell lymphoma (DLBCL), the most common non-Hodgkin lymphoma …

HIV infection and survival among women with cervical cancer

S Dryden-Peterson, M Bvochora-Nsingo… - Journal of Clinical …, 2016 - ascopubs.org
Purpose Cervical cancer is the leading cause of cancer death among the 20 million women
with HIV worldwide. We sought to determine whether HIV infection affected survival in …

[HTML][HTML] Diffuse large B-cell lymphoma in the HIV setting

M Huguet, JT Navarro, J Moltó, JM Ribera, G Tapia - Cancers, 2023 - mdpi.com
Simple Summary Non-Hodgkin lymphoma (NHL) is one of the most frequent HIV-related
neoplasms, and diffuse large B-cell lymphoma (DLBCL) is the most common subtype. In …

[HTML][HTML] Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general population

A Cingolani, A Cozzi Lepri, L Teofili, L Galli… - PLoS …, 2017 - journals.plos.org
Objectives to compare overall survival in HIV-associated lymphoma (HIV-L) and lymphoma
raising in HIV-negative population (nHIV-L) and to identify predictors of increased risk of …

HIV-related skin disease in the era of antiretroviral therapy: recognition and management

K Chelidze, C Thomas, AY Chang… - American journal of …, 2019 - Springer
Antiretroviral therapy (ART) has revolutionized the treatment and prognosis of people living
with HIV (PLHIV). With increased survival and improved overall health, PLHIV are …

[HTML][HTML] Clinical and molecular properties of human immunodeficiency virus-related diffuse large B-cell lymphoma

PS de Carvalho, FE Leal, MA Soares - Frontiers in Oncology, 2021 - frontiersin.org
Non-Hodgkin lymphoma is the most common malignancy affecting people living with HIV
(PLWH). Among its several subtypes, diffuse large B-cell lymphoma (DLBCL) is an important …

[HTML][HTML] Clinical characteristics and outcomes in HIV-associated diffuse large B-cell lymphoma in China: A retrospective single-center study

J Wu, Y Miao, C Qian, P Tao, X Wang, X Dong… - Journal of …, 2021 - ncbi.nlm.nih.gov
Human immunodeficiency virus (HIV) infection is associated with an increased risk of
aggressive lymphoma, especially diffuse large B cell lymphoma (DLBCL). There are few …

Genetic and phenotypic characterisation of HIV‐associated aggressive B‐cell non‐Hodgkin lymphomas, which do not occur specifically in this population: diagnostic …

MJ Baptista, G Tapia, AM Muñoz‐Marmol… - …, 2022 - Wiley Online Library
The frequency of aggressive subtypes of B‐cell non‐Hodgkin lymphoma (B‐NHL), such as
high‐grade B‐cell lymphomas (HGBL) with MYC and BCL2 and/or BCL6 rearrangement …

Outcomes of human immunodeficiency virus‐associated Burkitt lymphoma and diffuse large B‐cell lymphoma treated in Australia: A report from the Australasian …

KJC Lim, P Di Ciaccio, MN Polizzotto… - British Journal of …, 2023 - Wiley Online Library
Antiretroviral therapy (ART) has improved outcomes for human immunodeficiency virus‐
associated non‐Hodgkin lymphoma (HIV‐NHL). This is an analysis of 44 patients with HIV …